Photobiomodulation suppresses allergic contact dermatitis by inhibiting T‐cell activation
Contact Dermatitis · 2025-03 · 92 (3) · 187-196
DOI: 10.1111/cod.14713 ↗At a glance
Journal article in Contact Dermatitis, published online on 2024-10-10. Written by Jingfei Fu and 6 co-authors. Institution: Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruc…. Major MEDLINE topics: Dermatitis, Allergic Contact, T-Lymphocytes, Lymphocyte Activation, Low-Level Light Therapy. Cited 3 times so far (Crossref); 40 references. Funded by: National Nature Science Foundation of China, National Key R&D of Program of China, Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support.
Abstract (original language)
Background
Allergic contact dermatitis (ACD) is a dermal inflammatory disease caused by allergic reactions to substances that contact the skin. The hyperactivation of T cells plays an important role in its pathogenesis. Photobiomodulation (PBM) is an efficacious therapeutic approach for suppressing inflammatory diseases.
Objective
This study aimed to evaluate the potentially beneficial role of PBM in ACD models and investigate its possible mechanisms.
Methods
In this study, the ACD model of C57BL/6 mice was produced and treated with PBM, and the number of T cells was evaluated. In an in vitro study, naïve T cells were isolated and intervened with PBM. The markers of T cell activation were detected by flow cytometer. Transforming growth factor‐β (TGF‐β) and reactive oxygen species (ROS) were detected to investigate the mechanism.
Results
PBM effectively inhibited the inflammatory response by impeding the number of T cells in the ACD model. And in vitro studies showed that PBM could directly moderate the activation of naïve T cells and possess the capability to impede T cell activation via TGF‐beta signaling pathway.
Conclusion
Our finding elucidates the potential mechanism underlying the inhibitory effects of PBM in inflammatory diseases and furnishes a theoretical foundation for its clinical application.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, Peop…
- Beijing Laboratory of Oral Health, Capital Medical University, Beijing, People's Republic of China.
ORCID profiles: Yi Liu
Funding
- National Nature Science Foundation of China
- National Key R&D of Program of China
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
- Innovation Research Team Project of Beijing Stomatological Hospital, Capital Medical University
- Beijing Municipal Administration of Hospitals' Ascent Plan
- Young Scientist Program Of Beijing Stomatological Hospital, Capital Medical University
- Beijing Municipal Administration of Hospitals' Youth Programme
- National Natural Science Foundation of China
Cite
APA
Fu, J., Zhao, R., Jiang, Y., Chen, Y., Du, J., Liu, Y., & Xu, J. (2025). Photobiomodulation suppresses allergic contact dermatitis by inhibiting T‐cell activation. Contact Dermatitis, 92(3), 187-196. https://doi.org/10.1111/cod.14713
Vancouver
Fu J, Zhao R, Jiang Y, Chen Y, Du J, Liu Y, et al. Photobiomodulation suppresses allergic contact dermatitis by inhibiting T‐cell activation. Contact Dermatitis. 2025;92(3):187-196. doi:10.1111/cod.14713
BibTeX
@article{Fu2025,
author = {Fu, Jingfei and Zhao, Rui and Jiang, Yiyang and Chen, Yingyi and Du, Juan and Liu, Yi and Xu, Junji},
title = {Photobiomodulation suppresses allergic contact dermatitis by inhibiting T‐cell activation},
journal = {Contact Dermatitis},
year = {2025},
volume = {92},
number = {3},
pages = {187--196},
doi = {10.1111/cod.14713}
}
EUVIMED